You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bausch Lomb Ireland FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 211039 NDA Bausch & Lomb Incorporated 24208-734-05 1 BOTTLE, GLASS in 1 CARTON (24208-734-05) / 5 mL in 1 BOTTLE, GLASS 2020-03-20
Bausch Lomb Ireland FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 211039 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-732-05 1 BOTTLE, GLASS in 1 CARTON (68682-732-05) / 5 mL in 1 BOTTLE, GLASS 2021-03-25
Bausch Lomb Ireland FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE benoxinate hydrochloride; fluorescein sodium SOLUTION/DROPS;OPHTHALMIC 211039 NDA AUTHORIZED GENERIC Bausch & Lomb Americas Inc. 82260-734-05 1 BOTTLE, GLASS in 1 CARTON (82260-734-05) / 5 mL in 1 BOTTLE, GLASS 2020-03-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Fluorescein Sodium and Benoxinate Hydrochloride

Last updated: August 2, 2025


Introduction

In the pharmaceutical sector, sourcing high-quality active pharmaceutical ingredients (APIs) like Fluorescein Sodium and Benoxinate Hydrochloride is crucial for maintaining product efficacy, regulatory compliance, and patient safety. This report provides a comprehensive overview of leading suppliers globally, their manufacturing capabilities, geographic distribution, and strategic considerations for procurement professionals striving for reliable supply chains.


Fluorescein Sodium: Overview and Major Suppliers

Fluorescein Sodium is a synthetic organic compound predominantly used as a diagnostic agent in ophthalmology, particularly for fluorescein angiography, corneal examinations, and retinal imaging. Its stability, safety profile, and well-established manufacturing processes make it a staple in diagnostic medicine.

Key Suppliers

  1. Sigma-Aldrich / Merck KGaA

    • Overview: As one of the largest chemical and pharmaceutical ingredient providers worldwide, Merck offers pharmaceutical-grade Fluorescein Sodium for research and diagnostic purposes.
    • Capabilities: These suppliers maintain strict quality controls, Good Manufacturing Practice (GMP) compliance, and global distribution networks, ensuring supply stability.
    • Regulatory Status: Their APIs are often utilized in clinical settings, with certifications suitable for pharmaceutical and diagnostic use.
  2. Sinerga S.p.A.

    • Location: Italy
    • Profile: A specialized manufacturer of dyes, including fluorescein derivatives, Sinerga produces high-purity Fluorescein Sodium, serving both diagnostic and research markets.
    • Strengths: Focus on specialty dyes with strict quality assurance, ISO certifications, and extensive experience in ophthalmic diagnostic agents.
  3. MP Biomedicals

    • Location: United States
    • Overview: MP Biomedicals supplies laboratory-grade Fluorescein Sodium, catering to bench research, diagnostic, and pharmaceutical companies.
    • Advantages: Proven reliability, compliance with international standards, and extensive distribution channels.
  4. Kinbio Pharmaceutical

    • Location: China
    • Profile: A leading Chinese manufacturer of APIs and diagnostic dyes, Kinbio offers bulk Fluorescein Sodium meeting pharmaceutical standards.
    • Regulatory Note: Their products are increasingly recognized in global markets, with some certifications for export to regulated regions.
  5. Lonza Group (Lonza Walkersville Inc.)

    • Location: United States
    • Capabilities: Known for biopharmaceutical ingredients, Lonza also supplies high-grade chemical dyes, including fluorescein-based compounds.

Benoxinate Hydrochloride: Overview and Major Suppliers

Benoxinate Hydrochloride (also known as oxybuprocaine hydrochloride) is a local anesthetic agent predominantly utilized in ophthalmic anesthesia for procedures such as tonometry, gonioscopy, and foreign body removal.

Major Suppliers

  1. Santen Pharmaceutical Co., Ltd.

    • Location: Japan
    • Profile: A global leader in ophthalmic pharmaceuticals, Santen develops and supplies Benoxinate Hydrochloride as part of compound formulations and as a raw material for eye drops.
    • Strengths: Extensive R&D, regulatory expertise, and committed manufacturing capacity.
  2. Taj Pharmaceuticals Ltd.

    • Location: India
    • Overview: An established bulk API manufacturer with capabilities in electrolytes, anesthetics, and ophthalmic agents like Benoxinate Hydrochloride, catering to global markets.
    • Certifications: GMP, ISO 9001, and stringent quality control protocols.
  3. Dr. Reddy’s Laboratories

    • Location: India
    • Profile: A leading pharmaceutical manufacturer with a diversified portfolio, including ophthalmic APIs. They supply Benoxinate Hydrochloride for both generics and branded formulations.
    • Compliance: Approved by regulatory agencies globally, including the FDA and EMA.
  4. Hubei Mulin Pharmaceutical Co., Ltd.

    • Location: China
    • Capabilities: Produces ophthalmic anesthetic APIs, including Benoxinate Hydrochloride, with plans for expanding export markets. Quality assurance aligns with international standards.
  5. Piramal Enterprises Ltd.

    • Location: India
    • Insight: Known for custom synthesis and API manufacturing, Piramal offers high-purity Benoxinate Hydrochloride suitable for ophthalmic use, with extensive quality documentation.

Regional Analysis & Strategic Considerations

Global Production Landscape

The landscape shows a concentration of suppliers in Asia, notably India and China, driven by cost advantages and manufacturing scale. European and Japanese firms emphasize quality, regulatory compliance, and innovation, often serving specialty markets.

Key Supply Chain Factors

  • Regulatory Compliance: Suppliers must meet stringent standards such as GMP, ISO standards, and regional regulatory approvals (FDA, EMA, PMDA).
  • Quality Assurance: High-purity APIs with Certificate of Analysis (CoA) and stability studies underpin reliable sourcing.
  • Supply Stability: Partnership with diversified suppliers mitigates risks of shortages caused by geopolitical or pandemic-related disruptions.
  • Pricing Dynamics: Cost considerations often lead companies to multiple sourcing strategies, balancing quality and affordability.

Emerging Market Trends

  • Increased outsourcing to Chinese and Indian manufacturers supports cost-effective procurement, although quality validation remains essential.
  • Governments and agencies pushing for stricter API quality standards influence supplier registration and compliance.
  • Strategic partnerships and long-term contracts are increasingly favored to ensure consistent supply.

Regulatory and Certification Considerations

Suppliers capable of providing APIs that comply with international standards (USP, EP, JP) and possess valid documentation (COA, DMF, CEP) are preferred for pharmaceutical applications. Ensuring that suppliers comply with regional import regulations is critical for seamless market entry.


Conclusion

Healthcare providers and pharmaceutical companies seeking reliable sources of Fluorescein Sodium and Benoxinate Hydrochloride should prioritize suppliers with a strong track record in high-quality manufacturing, regulatory compliance, and supply chain resilience. Notable global suppliers include Merck (Sigma-Aldrich), Sinerga, MP Biomedicals, Santen, and Indian manufacturers like Taj Pharmaceuticals and Piramal Enterprises.


Key Takeaways

  • Diversify supply sources to avoid disruptions, particularly given regional concentration in Asia.
  • Prioritize suppliers with extensive regulatory documentation and certifications aligned with target markets.
  • Evaluate manufacturing capacity and quality control protocols to ensure API purity and stability.
  • Align procurement strategies with market trends, balancing cost, quality, and regulatory complexity.
  • Stay vigilant on evolving international standards to maintain compliance and optimize supply chain robustness.

Frequently Asked Questions

1. What standards should suppliers meet for pharmaceutical-grade Fluorescein Sodium and Benoxinate Hydrochloride?
Manufacturers must comply with GMP, ISO certifications, and region-specific standards such as USP, EP, or JP. Comprehensive documentation, including COA and DMF, is essential.

2. Are there regional preferences for sourcing these APIs?
While global companies often prefer suppliers from Japan, the US, and Europe for quality assurance, Asian manufacturers from India and China are favored for cost efficiency, provided compliance is maintained.

3. How can buyers verify supplier credentials?
Due diligence involves reviewing certifications, audit reports, OEM capacity, regulatory approvals, and conducting site audits if necessary.

4. What are the risks associated with sourcing from unverified suppliers?
Risks include substandard quality, regulatory non-compliance, supply shortages, and potential legal repercussions.

5. How does the regulatory environment impact supplier selection?
Regulatory changes and regional import requirements influence supplier qualification; selecting suppliers with a global compliance track record simplifies market entry.


References

[1] Merck KGaA, Sigma-Aldrich product specifications, 2023.
[2] Sinerga S.p.A., Company profile and product datasheet, 2023.
[3] MP Biomedicals, API catalog, 2023.
[4] Santen Pharmaceutical Co., Ltd., Global product portfolio, 2023.
[5] Taj Pharmaceuticals Ltd., API manufacturing capabilities, 2023.


Note: The above information aims to guide procurement strategies; actual supplier engagement requires due diligence tailored to specific market and quality requirements.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.